Anti-angiogenic agents and methods of use

Details Anti-angiogenic agents and methods of use Anti-angiogenic agents and methods of use

A - Human Necessities

61

K

A61K 31/343 (2006.01) A61P 9/00 (2006.01)

Patent

CA 2683316

The present disclosure relates generally to treating or preventing diseases associated with angiogenesis by administering to a patient certain compounds found to inhibit or substantially reduce angiogenesis. Compounds employed according to the present disclosure exhibit good anti-angiogenic activity as well as demonstrate a prophylactic effect for preventing and substantially reducing angiogenesis. Examples of such compounds include Ritanserin, Amiodarone, Terfenadinc, Perphenazine, Bithionol, and Clomipramine

Affiliated with

Also associated with

Rating

Anti-angiogenic agents and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-angiogenic agents and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-angiogenic agents and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1443285